UNITED STATES SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
FORM 4
STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP
( ) Check this box if no longer subject to Section 16.
Form 4 or Form 5 obligations may continue. See Instructions 1(b).
1. Name and Address of Reporting Person
Lehmann, Nolan
515 W. Greens Rd. Ste. 500
Houston, TX 77067
2. Issuer Name and Ticker or Trading Symbol
Paracelsus Healthcare Corporation
PLHC.OB
3. IRS or Social Security Number of Reporting Person (Voluntary)
4. Statement for Month/Year
08/31/2000
5. If Amendment, Date of Original (Month/Year)
6. Relationship of Reporting Person(s) to Issuer (Check all applicable)
(X) Director ( ) 10% Owner ( ) Officer (give title below) ( ) Other
(specify below)
Director
7. Individual or Joint/Group Filing (Check Applicable Line)
(X) Form filed by One Reporting Person
( ) Form filed by More than One Reporting Person
<TABLE>
<CAPTION>
___________________________________________________________________________________________________________________________________
Table I -- Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned |
___________________________________________________________________________________________________________________________________|
1. Title of Security |2. |3. |4.Securities Acquired (A) |5.Amount of |6.Dir |7.Nature of Indirect |
| Transaction | or Disposed of (D) | Securities |ect | Beneficial Ownership |
| | | | Beneficially |(D)or | |
| | | | | A/| | Owned at |Indir | |
| Date |Code|V| Amount | D | Price | End of Month |ect(I)| |
___________________________________________________________________________________________________________________________________|
<S> <C> <C> <C><C> <C> <C> <C> <C> <C>
Common stock |08/03/|J | |117 |A |Note 1 |16,832 |D | |
|2000 | | | | | | | | |
-----------------------------------------------------------------------------------------------------------------------------------|
Common stock - previously r| | | | | | |1,000 |I |By spouse |
eported | | | | | | | | | |
-----------------------------------------------------------------------------------------------------------------------------------|
| | | | | | |540,481 |I |Note 2 |
-----------------------------------------------------------------------------------------------------------------------------------|
| | | | | | |2,018,213 |I |Note 3 |
-----------------------------------------------------------------------------------------------------------------------------------|
| | | | | | |------------ | | |
-----------------------------------------------------------------------------------------------------------------------------------|
| | | | | | |2,576,526 | | |
-----------------------------------------------------------------------------------------------------------------------------------|
| | | | | | |======== | | |
-----------------------------------------------------------------------------------------------------------------------------------|
___________________________________________________________________________________________________________________________________|
<CAPTION>
___________________________________________________________________________________________________________________________________
Table II -- Derivative Securitites Acquired, Disposed of, or Beneficially Owned |
___________________________________________________________________________________________________________________________________|
1.Title of Derivative |2.Con- |3. |4. |5.Number of De |6.Date Exer|7.Title and Amount |8.Price|9.Number |10.|11.Nature of|
Security |version |Transaction | rivative Secu |cisable and| of Underlying |of Deri|of Deriva |Dir|Indirect |
|or Exer | | | rities Acqui |Expiration | Securities |vative |tive |ect|Beneficial |
|cise | | | red(A) or Dis |Date(Month/| |Secu |Securities |(D)|Ownership |
|Price of| | | posed of(D) |Day/Year) | |rity |Benefi |or | |
|Deriva- | | | |Date |Expir| | |ficially |Ind| |
|tive | | | | A/|Exer-|ation| Title and Number | |Owned at |ire| |
|Secu- | | | | | D |cisa-|Date | of Shares | |End of |ct | |
|rity |Date |Code|V| Amount | |ble | | | |Month |(I)| |
___________________________________________________________________________________________________________________________________|
<S> <C> <C> <C> <C><C> <C> <C> <C> <C> <C> <C> <C> <C> <C>
No change | | | | | | | | | | | | | | |
-----------------------------------------------------------------------------------------------------------------------------------|
| | | | | | | | | | | | | | |
___________________________________________________________________________________________________________________________________|
</TABLE>
Explanation of Responses:
Note 1 - Shares received from class settlement fund in connection with the
settlement of shareholders litigation.
Note 2 - Shares owned by Equus Capital Partners, L.P. ("ECP"). Mr.Lehmann is a
director and president of ECP's Managing Partner, Equus Capital
Management
Corporation.
Note 3 - Shares owned by Equus II Incorporated ("Equus II"). Mr.Lehmann is a
director and president of Equus II and Equus II's Managing Partner,
Equus Capital Management
Corporation.
SIGNATURE OF REPORTING PERSON
Mai-Phuong N.Garland, Attorney-inFact
DATE
09/11/2000
